U.S. Leading Ophthalmic Diseases Markets

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

The leading ophthalmic diseases in the U.S. are glaucoma, age-related macular degeneration (AMD), diabetic retinopathy (DR), and cataracts. The market opportunity in these areas is large and untapped, because a significant portion of the patient base is undiagnosed, and there is still a lack of a curative treatment for all of these diseases. This report summarizes, in detail, the demand and business opportunities in each of the four diseases, as well as the research projects ongoing for developing innovative therapies. Altogether, this report gives an excellent overview of what can be expected to happen in the near future in the field of the most important ophthalmic diseases.

Table of Contents

U.S. Leading Ophthalmic Diseases Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Leading Ophthalmic Diseases Markets, U.S. Leading Ophthalmic Diseases MarketsOverviewIntroductionMarket DriversMarket RestraintsForecasts and TrendsDemand AnalysisMarket and Technology TrendsFrost & Sullivan Market Engineering AwardsBrand Awareness Development Award- Bausch & LombTechnology Innovation Award - Oculex PharmaceuticalsBusiness Development Strategy Award - Alcon LaboratoriesMarket Penetration Award - Merck & Co.Product Launch Strategy Award - Novartis OphthalmicsU.S. Leading Ophthalmic Diseases Markets, U.S. Glaucoma Pharmaceuticals MarketOverviewIntroductionGlaucoma TreatmentsMarket DriversMarket RestraintsChallengesMarket Engineering AnalysisForecasts and TrendsRevenue ForecastsRevenue Forecast AssumptionsDemand AnalysisMarket and Technology TrendsResearch DirectionsPricing TrendsCompetitive AnalysisCompetitive StructureMarket Share AnalysisProduct Analysis - MitoticsProduct Analysis - Beta BlockersProduct Analysis - Adrenergic AgonistsProduct Analysis - Carbonic Anhydrase InhibitorsProduct Analysis - Prostaglandin AnaloguesStrategic RecommendationsStrategic Recommendations for Market Challenge 1Strategic Recommendations for Market Challenge 2Strategic Recommendations for Market Challenge 3U.S. Leading Ophthalmic Diseases Markets, U.S. Age-Related Macular Degeneration Pharmaceuticals MarketOverviewIntroductionDemand AnalysisThe Business OpportunityMarket IssuesMarket and Technology TrendsCompetitive StructureResearch DirectionsU.S. Leading Ophthalmic Diseases Markets, U.S. Diabetic Retinopathy Pharmaceuticals MarketOverviewIntroductionDemand AnalysisThe Business OpportunityMarket and Technology TrendsCompetitive StructureResearch DirectionsU.S. Leading Ophthalmic Diseases Markets, U.S. Cataract Pharmaceuticals MarketOverviewIntroductionDemand AnalysisMarket and Technology TrendsCompetitive StructureResearch DirectionsU.S. Leading Ophthalmic Diseases Markets, Decision Support DatabaseCataractBlindness due to CataractPercentage Blindness due to CataractNumber of Cataract SurgeryDemographyMale Population over 65 Years of AgeFemale Population over 65 Years of AgeTotal Population over 65 Years of AgePopulation between 45 to 64 Years of AgePercentage of Population over 45 years of Age




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Nov-17

Region : North America

Release Date : 15-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.